desired protein intake for individuals with diabetes. Diabetes Care 11:143- 48, 1988 E stablishing appropriate recommendations for protein intake in the management of diabetes requires examination of the role that dietary protein plays in overall health, in the control of diabetes, and in the risks to health posed by diabetes. Achieving metabolic control and delaying and/or preventing diabetic complications have previously been established as primary goals for the dietary management of diabetes. Although the primary function of dietary protein is for growth and tissue maintenance, dietary protein may play a role in the regulation of glucose metabolism and in the development of diabetic renal complications. Approximately half of protein intake is available as glucose. Dietary composition also affects secretion of insulin and counterregulatory hormones. One-third of individuals with insulin-dependent diabetes mellitus (IDDM) and one-fifth of those with noninsulin-dependent diabetes mellitus (NIDDM) have nephropathy 15 yr after diagnosis of diabetes (1) .
High protein intake and hyperglycemia can increase the glomerular filtration rate and the work load of the kidney. There is growing evidence from clinical studies that the progression of renal disease is delayed by early protein restriction (2) . More studies are needed to assess early risk of diabetic nephropathy and to determine whether protein restriction alters the course of diabetic nephropathy.
This article examines research literature regarding the impact of dietary protein on determinants of metabolic control and on the risk of nephropathy. The rationale for the 1986 American Diabetes Association recommendation is explored.
ROLE OF PROTEIN IN DIABETIC CONTROL
Clearly, the primary function of dietary protein is to provide amino acids required for tissue growth and maintenance. When amino acids are not needed for this function, they are deaminated for use as energy. In diabetes, how amino acids affect energy metabolism partially determines the impact of dietary protein on diabetes control.
Most amino acids are glucogenic; isoleucine, tyrosine, and phenylalanine are glucogenic and ketogenic. Leucine is the only amino acid that cannot be converted to glucose (3) . In the 1930s it was established that -5 0 % of the protein is available glucose (4) . The prediction of available glucose is based on comparing postprandial glucose effect of a protein with a carbohydrate meal.
Dietary protein plays a major role in the hormonal regulation of energy metabolism or amino acids. Numerous studies have evaluated the impact of protein intake on insulin secretion and plasma glucose levels (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . In normal subjects, a 40% protein and 20% carbohydrate diet increased circulating insulin levels after meals without an increase in glucose (5). A 2-wk diet consisting exclusively of seafood did not cause the deterioration in glucose tolerance that is usually associated with a diet devoid of carbohydrate (12) . A study that evaluated the effect of dividing breakfast into two portions consumed 2 h apart found that the first portion was associated with enhanced insulin secretion (14) . Evaluation of IDDM subjects showed that "the insulin requirements varied only slightly" with diets that varied from >40% of calories as protein with <25% carbohydrate to -1 5 % protein with -7 0 % carbohydrate (11) .
Insulin secretion also appears to be enhanced by specific amino acids. Leucine, which is not glucogenic, and arginine, which is glucogenic, have been shown to stimulate insulin secretion (14) (15) (16) . Glucagon secretion is also stimulated by arginine and by oral consumption of protein (16, 17) .
It has been suggested that a higher-protein diet may benefit individuals with NIDDM by enhancing insulin secretion and that individual preference should determine protein intake (5) . A high-protein diet (containing 40% of the total calories as protein) has been advocated for all diabetic individuals on the basis of improved metabolic control and lower insulin requirement (18) . The consumption of protein followed by carbohydrate to enhance diabetic control has also been advocated (13) . A "protein-sparing" low-calorie high-protein diet (1.5 g/kg) to facilitate weight loss while protecting lean body tissue has been recommended for obese individuals with NIDDM (19, 20) .
RISK OF COMPLICATIONS
The recommendation for protein intake must consider the potential impact of dietary protein on diabetic complications. A low-protein diet has been the standard approach for treating end-stage renal disease (ESRD) associated with diabetes (21) . The role of protein in the development and progression of diabetic nephropathy has not been clearly defined. One-third of individuals with IDDM and one-fifth of those with NIDDM have diabetic nephropathy 15 yr after diagnosis (22) .
The histological changes that occur in diabetic nephropathy involve glomerulosclerosis, hyalinosis of afferent and efferent glomerular arterioles, and sometimes pyelonephritis. These changes are more common in IDDM but can occur in either IDDM or NIDDM (23) .
Glomerular filtration rate declines and renal blood flow decreases with age in healthy individuals. These changes are associated with sclerosis of 10-30% of the glomeruli between the 4th and 8th decade of life. It has been hypothesized that, although this loss is not serious by itself, glomerulosclerosis is accelerated by other diseases such as diabetes that destroy renal mass. This hypothesis, first suggested by Addis (25) but later termed the Brenner hypothesis, also suggests that a high protein intake increases the work load by increasing renal blood flow and glomerular filtration rate and ultimately accelerates glomerulosclerosis (26) (27) (28) (29) .
The development of clinical nephropathy appears to be related to increased interstitial tissue and glomerular mesangium and the closing of glomerular capillaries (30) (31) (32) (33) . The number of Kimmelstiel-Wilson lesions or the degree of arteriolar hyalinosis or exudative lesions does not seem to distinguish patients from those without clinical nephropathy, and the best indicator of the absence of clinical nephropathy appears to be the number of open capillaries.
In IDDM, five stages of nephropathy have been identified. At the time of diagnosis there is hyperfiltration and renal hypertrophy, which is reversed when insulin therapy is instituted but may persist for years if metabolic control is poor (34) . This initial stage is difficult to assess and may not exist in NIDDM with its gradual onset. Improved glycemic control with concurrent reduction in proteinuria has been reported in NIDDM (35) . Subclinical microalbuminuria was diminished in obese individuals with glucose intolerance or NIDDM who were fed a hypocaloric diet of 500 cal with 50 g carbohydrate and an unspecified quantity of protein. It appears that the reduction in proteinuria may be the result of improved glycemic control or possibly low protein intake. Glomerular hyperfiltration was significantly reduced in experimental diabetes when an 8% protein diet was compared with a 24% protein diet in streptozocin-treated rats (36) . This dietary experiment was initiated during the initial stage of diabetes, and the low-protein diet was associated with minimal mesangial changes in rat kidneys.
The second stage is manifested with the development of glomerular lesions without clinical disease (24) . This stage is considered silent and develops over many years. It consists of structural lesions that would be evident on biopsy but without clinical or laboratory signs of renal disease. Predictors of progression beyond this stage are not well understood.
The second stage is characterized by the absence of clinical albuminuria, but the onset of exercise-induced albumin excretion is abnormal after a few years (24) . Some individuals with diabetes never progress beyond this stage. There has been no evaluation of the role dietary protein may play during this stage when abnormal morphology develops.
The third stage, incipient diabetic nephropathy, is considered the forerunner of overt diabetic nephropathy. It is characterized by abnormally elevated urinary albumin excretion as measured by radioimmunoassay. Albumin excretion of 15-300 (xg/min signals entry into this stage (24) . A gradual increase in albuminuria occurs in this stage over a period of years. In a prospective study of IDDM patients, an albumin excretion rate of >30 (xg/min measured by radioimmunoassay predicted the later development of clinical nephropathy (37) . There are questions that need further investigation about factors that determine permeability of basement membranes to large molecules (38) (39) (40) . Factors such as metabolic control and/or any blood pressure elevation appear to determine further progression of renal change.
Blood pressure gradually increases at this stage. An exercise test has been developed to evaluate the severity of disease and the impact of antihypertensive therapy on renal function and albumin excretion (40) (41) (42) (43) (44) (45) (46) (47) (48) . Whether the exercise test can be used to evaluate the role of excess dietary protein or the potential benefit of protein restriction is not known. The exact mechanism causing the increased albuminuria during exercise in incipient nephropathy may be related to microcirculatory changes in the glomeruli and renal autoregulation in connection with arteriolar hyalinosis, but renal tubular alterations are not thought to be involved (41) .
The severity of diffuse mesangial thickening may be the primary morphological feature of diabetic nephropathy, and the thickened glomerular basement membrane may not explain the alteration of glomerular selectivity associated with the clinical manifestation of diabetic nephropathy (33) . It has been suggested that overt proteinuria, hypertension, and declining glomerular filtration rate can be found in patients with advanced mesangial lesions who have <10% hyalinized glomeruli. The remnant-kidney hypothesis suggests that compensatory mechanisms to reduce the number of nephrons establishes hemodynamic forces in the glomerulus, resulting in structural changes to produce proteinuria and hypertension (49) (50) (51) .
In incipient diabetic nephropathy, whether reducing hyperfiltration by protein restriction would preserve kidney function has not been clearly demonstrated. However, the evidence from human and animal studies seems to indicate that the increase in renal blood flow, glomerular filtration, and the structural changes associated with excessive protein ingestion may all play a role in the loss of kidney function (49) . It appears that high protein intake may increase the work load of the diabetic kidney, and protein restriction could restore glomerular hemodynamics before structural changes have advanced to overt nephropathy.
In the fourth stage, overt diabetic nephropathy, the structural changes are associated with altered kidney function. This stage is characterized by persistent proteinuria of >0.5 g/day (24) . It has been estimated that the fall in glomerular filtration rates is ~1 ml • min~1 • mo~\ but antihypertensive therapy reduces the rate of fall by ~60% and thereby delays but does not prevent the further progression to ESRD (24) . Protein restriction may delay the progression of overt diabetic nephropathy to ESRD.
A diet with 0.6 g protein/kg of diet had been used to delay the progression of nephrotic syndrome to ESRD in a group of patients with a mean serum creatinine of 2.28 mg/dl (52, 53) . In this group of 25 patients, only 3 showed evidence of deterioration of renal function during a 5-yr period, compared to 40% of patients in a similar group who were treated with a free diet that averaged 70 g protein/day. Even though this study was not a randomized trial and only a few patients had diabetic nephropathy, it does provide suggestive clinical evidence for instituting protein restriction for patients with overt diabetic nephropathy before developing ESRD.
In another study, 24 patients with chronic renal failure were fed a diet with 20-30 g mixed-quality protein supplemented with amino acids and their keto analogues. These patients had a mean creatinine of 7.6 mg/dl, and the dietary treatment regimen was associated with slowing or arresting of the predicted rise of serum creatinine (54) .
In a prospective randomized study of 228 patients, early moderate protein restriction retarded the development of ESRD. Patients were stratified on the basis of creatinine clearance and were randomized into four groups. The protein restrictions were 0.6 g/kg for a creatinine clearance of 31-60 mM and 0.4 g/kg for creatinine clearance of 10-30 mM (55). One hundred fortynine of the patients were followed for >18 mo. The patients on the protein-restricted diet showed a fall in serum protein, urea, and phosphorus. Regression analysis of the reciprocol of serum creatinine against time revealed a rate of progression three to five times lower in the protein restricted groups than in the control group with a free diet.
The protein-restricted diet was associated with initial hunger, but intensive counseling with the dietitian resolved the problem without adversely affecting excretion of urea or phosphorus. At 3 and 6 mo, a higher proportion of patients in the protein-restricted groups indicated dissatisfaction that diminished over time.
Most studies of low-protein diets in chronic renal failure are based on a mixed patient population with varied causes of renal failure (52) (53) (54) (58) (59) (60) (61) (62) (63) (64) (65) (66) (67) (68) (69) . Very low protein diets of 20-30 g supplemented with keto acids have been used to improve or maintain protein nutrition in patients who would otherwise require dialysis or transplant (54) . There is some debate as to the role of essential amino acid and keto acid supplements in preventing catabolism at various levels of protein restriction. Generally, amino acid supplements appear to be indicated when protein is restricted to 30 g and keto analogues to 20 g. More protein, 5-10 g, is usually added for proteinuria >5 g/day. Dialysis is associated with protein catabolism, and monitoring of protein status is needed if a low-protein diet is used in combination with dialysis. For patients with diabetes, a low-protein diet and/or dialysis may not be the therapy of choice based on survival studies.
Evaluation of the mechanism by which protein restriction retards the progression of diabetic nephropathy is beyond the scope of these studies. However, the authors of the randomized trial did conclude "the results might support the Brenner hypothesis on dietary protein intake and the progressive nature of kidney diseases and the hyperfiltration theory" (55) . In addition, they felt that "preliminary results indicated that patients with chronic glomerular nephritis do better than patients with nephrosclerosis or polycystic kidney disease" (55) . More research and functional tests, especially in diabetic individuals, are needed to determine the efficacy of protein restriction in the incipient and overt stages of diabetic nephropathy.
ESRD in diabetes is characterized by uremia nephropathy, and both uremia and IDDM are associated with abnormalities in the metabolism of amino acids (56) . Insulin deficiency results in an elevation of fasting branched-chain amino acids and diminished uptake after a protein feeding. In contrast, uremia is associated with decreased fasting branched-chain amino acid. However, both conditions are associated with hepatic sensitivity to glucagon, glucose overproduction, and hyperglycemia after protein ingestion. On the other hand, when diabetic patients with uremia are treated with a low-protein diet of 20-30 g/day (58), control of blood glucose is reported to be achieved with no or only minor adjustments in insulin dosage. The glomerular filtration rate is <10 ml/min, and the primary structural change associated with end-stage renal failure is glomerular closure. There may be some decrease in albumin excretion associated with nephron closure (24) . Dialysis and renal transplant are primary modes of treatment for diabetic end-stage renal failure. For diabetic patients, the 3-yr survival rate on dialysis is lower than for any other cause of renal failure (70) . It is unlikely that manipulation of protein intake could alter the relative diabetic survival rate. However, renal transplant from a related donor more than doubles the survival rate, from 39 to 82%, making the diabetic survival rate comparable to other causes of renal failure (71) . The role of protein in diabetes after renal transplant has not been evaluated. However, hyperfiltration associated with protein intake is likely to be associated with nephropathy in the new kidney.
DIETARY PROTEIN RECOMMENDATIONS
A dietary intake with 12-20% of calories from protein provides flexibility in food selection but exceeds the actual need for individuals with diabetes who do not have evidence of renal complications. The daily adult Recommended Dietary Allowance (RDA) for protein is 0.8 g/kg body wt, with an additional 30 g for pregnancy and lactation (72) . Protein need is also increased during an acute catabolic state associated with physiological stress such as surgery and wound healing. Patients who have evidence of malnutrition or who need enteral or parenteral nutrition support are likely to have an increased protein requirement.
Efforts to increase soluble dietary fiber may increase vegetable protein intake, which can be used as a substitute for animal protein rather than to increase total protein intake. Protein from animal sources is generally more digestible than vegetable sources and could thereby be more available for urea production. Whether protein from animal sources increases the work load of the kidney is unknown.
Diabetic individuals with early structural renal change may be identified with an exercise test to induce albumin excretion. Limited joint mobility appears to be an indication of glycosylation of tissues and has been associated with microvascular complications (73, 74) . Assessment of joint mobility may potentially become a screening tool for nephropathy. Further research is needed to confirm these as screening tools. Reducing protein intake to the RDA may be helpful at the preclinical stage. In incipient diabetic nephropathy there is growing evidence that restriction of protein intake may prevent or delay progression of nephropathy. In overt diabetic nephropathy in which albumin excretion exceeds 500 mg/day, protein restriction may vary from 0.4 to 0.8 g/kg, depending on the patient's willingness to modify dietary intake, quality of life, and other nutritional considerations.
If the protein restriction is <40 g/day, serum albumin must be monitored, and essential amino acids may need to be supplemented. If the daily protein intake is 20-30 g, keto analogue supplementation should also be considered.
The use of protein restriction as the primary mode of therapy or in combination with dialysis in uremia-induced diabetic nephropathy may not be desirable if renal transplant is feasible. However, protein restriction may be desirable to avoid hyperfiltration in the new kidney.
